VEGFA and diabetes mellitus: Neovascular AMD, DME and proliferative DR share similar VEGF-driven pathophysiologic pathways, and VEGF inhibitors are effective as treatments for these conditions (Antonetti et al., 2012; Bandello et al., 2013; Writing Committee for the Diabetic Retinopathy Clinical Research Network et al., 2015; Cohen and Gardner, 2016; Pearce et al., 2020).